Biogen (Oral Solid Dose Facility)
Biogen discovers, develops and manufactures therapies for serious neurological diseases. This site houses oral solid dose and anti-sense oligonucleotide production, packaging and fill/finish operations, as well as a Global Business Services center.
Employment range in NC
Primary site activity
All company activities
Products on market
Avonex, Plegridy, Tecfidera, Tysabri, Spinraza